CEBPB and cancer: Importantly, the impact of lucicebtide on macrophage polarization is likely to act in concert with its direct cytotoxicity in C/EBPβ-driven cancers and raises the potential that the target patient population for lucicebtide therapy may extend beyond only cancer types driven by C/EBPβ.